Mathey D G, Schofer J, Bleifeld W
Dtsch Med Wochenschr. 1985 Nov 1;110(44):1681-5. doi: 10.1055/s-2008-1069069.
To examine whether the limitation in infarct size after effective thrombolytic therapy is time-dependent the relationship between left ventricular wall motion in the infarct region and the time interval between onset of symptoms and intracoronary streptokinase infusion was investigated. The relationship was significant: When intracoronary thrombolytic therapy was begun within 2 hours, wall motion was almost always within normal limits, whereas the probability of wall motion improvement fell to less than 50%, when treatment was begun later. As a further step a lysis procedure was examined which took account of these findings: the intravenous bolus injection of urokinase. Approximately one hour after bolus injection coronary patency could be demonstrated angiographically in 60% of the infarct patients. A clinically relevant limitation of the infarct size was found in those patients in whom lysis therapy could be begun within 2 hours. On the basis of these findings, a thrombolytic therapy seems to be indicated in all patients with acute myocardial infarction when lysis treatment can be begun within 2 hours. The intravenous urokinase therapy, by virtue of its simplicity, is an alternative to intravenous streptokinase therapy.
为了研究有效溶栓治疗后梗死面积的限制是否具有时间依赖性,我们调查了梗死区域左心室壁运动与症状发作至冠状动脉内输注链激酶时间间隔之间的关系。这种关系很显著:当在2小时内开始冠状动脉内溶栓治疗时,壁运动几乎总是在正常范围内,而当治疗较晚开始时,壁运动改善的概率降至50%以下。作为进一步的步骤,我们研究了一种考虑到这些发现的溶栓程序:静脉推注尿激酶。推注后约一小时,60%的梗死患者经血管造影显示冠状动脉通畅。在那些能够在2小时内开始溶栓治疗的患者中发现了梗死面积具有临床意义的限制。基于这些发现,对于所有急性心肌梗死患者,当能够在2小时内开始溶栓治疗时,似乎都应进行溶栓治疗。静脉注射尿激酶疗法因其操作简单,是静脉注射链激酶疗法的一种替代方法。